Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 15, 2026 07:00 ET | Source: Libertex

Understanding Spreads, Fees and Overnight Costs in CFD Trading

Libertex breaks down how spreads, commissions and overnight financing add up to the total cost of a CFD trade as EU regulators focus on cost transparency.
October 15, 2026 07:00 ET | Source: Eclipse Life Sciences

Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Eclipse Life Sciences, Inc., a privately held clinical-stage biopharmaceutical company developing next-generation therapies for...
October 15, 2026 07:00 ET | Source: Flagship Communities Real Estate Investment Trust

Flagship Communities Real Estate Investment Trust Announces Sixth Consecutive Cash Distribution Increase

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (TSX:MHC.U)...
October 15, 2026 07:00 ET | Source: Brunswick Exploration

Brunswick Exploration Announces 302 Metre-Wide Spodumene-Bearing Pegmatite Interval at the Anatacau Main Project

MONTREAL, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to report the results of drill hole AN-26-17 which...
October 15, 2026 07:00 ET | Source: R1 Therapeutics

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026
October 15, 2026 07:00 ET | Source: OMass Therapeutics

OMass Therapeutics Announces $310 Million Series C Financing to Advance Portfolio of Small Molecule Therapeutics in Endocrinology and Immunology

Financing co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with strong participation from additional new and existing investors Proceeds to advance MC2 receptor...
October 15, 2026 07:00 ET | Source: DataXray

Ohalo becomes DataXray, adopting the name its customers already use

Ohalo today announced that it is now DataXray. The company is taking the name of its platform, the one its customers already know.
October 15, 2026 07:00 ET | Source: Immunocore Holdings plc

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes The Phase 1 trial will assess the...
October 15, 2026 07:00 ET | Source: First Advantage Corporation

First Advantage to Release Third Quarter 2026 Financial Results and Hold Investor Conference Call on November 5, 2026

ATLANTA, Oct. 15, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a global software and data company, will issue its third quarter 2026 financial results on Thursday, November 5,...
October 15, 2026 07:00 ET | Source: PyroGenesis Inc.

PyroGenesis Completes Seven-System Drosrite™ Deployment at World’s Largest Aluminum Complex

MONTREAL, Oct. 15, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering...